PROCEPT BioRobotics Corporation Proceeds from Common Stock Issued
PROCEPT BioRobotics Corporation (PRCT) reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-02-26
- PROCEPT BioRobotics Corporation proceeds from issuance of common stock for the quarter ending 2024-12-31 was $164.52M.
- PROCEPT BioRobotics Corporation proceeds from issuance of common stock for the quarter ending 2023-12-31 was $0.00.
- PROCEPT BioRobotics Corporation proceeds from issuance of common stock for the quarter ending 2023-09-30 was $159.99M.
- PROCEPT BioRobotics Corporation proceeds from issuance of common stock for the quarter ending 2022-12-31 was $0.00.
- PROCEPT BioRobotics Corporation proceeds from issuance of common stock for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PROCEPT BioRobotics Corporation proceeds from issuance of common stock for fiscal 2024 was $164.52M, a 1.74% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation proceeds from issuance of common stock for fiscal 2023 was $161.71M.
- PROCEPT BioRobotics Corporation proceeds from issuance of common stock for fiscal 2022 was $0.00.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | ||||||
| 2024-12-31 | $164.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $164.52M 10-K · filed 2026-02-26 | |||||
| 2024-10-31 | $164.50M 10-K · filed 2025-02-27 | ||||||
| 2024-09-30 | $0.00 10-Q · filed 2024-10-28 | ||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $159.99M derived: sum of 2 quarters · filed 2026-02-26 | $161.71M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $159.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | $161.71M 10-Q · filed 2024-10-28 | |||||
| 2023-08-31 | $161.70M 10-K · filed 2024-02-28 | ||||||
| 2023-06-30 | $1.72M 10-Q · filed 2023-07-28 | ||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.29M derived: sum of 2 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | $2.41M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | $1.29M 10-Q · filed 2022-11-04 | ||||
| 2022-06-30 | $1.29M 10-Q · filed 2023-07-28 | ||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | |||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |